Recruiting 25 SCD family advocates from Prince George's County , Fairfax County and D.C. Wards 7 and 8 through community health partners, hospital social workers, and PHS's Sickle Cell Stories network, then establishing the tri-state coalition's governance structure.
A six-module curriculum covering the SCD policy landscape, legislative process navigation, testimony and storytelling for policy impact, coalition building, media engagement, and health equity framing, through virtual workshops, in-person sessions, and peer mentoring circles. Each advocate drafts a capstone policy brief on SCD care coordination.
Three regional Sickle Cell Policy Forums, one per jurisdiction with 50 to 75 participants each, featuring advocate testimony, clinical panels, and structured dialogue with legislators and health officials. The phase culminates in an advocacy day in Annapolis with the Maryland General Assembly.
Trained advocates transition into ongoing DMV SCD Policy Coalition working groups. We measure knowledge gains and advocacy engagement, document outcomes, and develop a replication framework so other regions can implement similar accelerator models.
The Accelerator is an open invitation to everyone who believes sickle cell families deserve a seat at the policy table.
If you are a patient, parent, caregiver, or adult survivor living in Maryland, D.C., or Virginia, apply to become one of our 25 trained family advocates. No prior policy experience needed, only your story and your commitment.
If you represent an SCD organization, a community health center, a hospital, or a faith community, join the DMV SCD Policy Coalition and add your voice to a unified tri-state agenda.
Clinicians, researchers, and policy professionals can contribute as training faculty, forum panelists, and mentors to emerging advocates.
Attend a Sickle Cell Policy Forum, share our advocates' stories, and help amplify a movement where the people most affected by sickle cell disease lead the change: policy made with the community, not merely about it.
Supported by an independent education grant from Pfizer.